Skip to content

Efficacy and safety of Tan-Re-Qing Capsule in the treatment of acute influenza:a randomized double-blind placebo-controlled trial

Efficacy and safety of Tan-Re-Qing Capsule in the treatment of acute influenza:a randomized double-blind placebo-controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019454
Enrollment
Unknown
Registered
2018-11-12
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

Group 1:Tan-Re-Qing capsule

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) The course of disease is = 36 hours; (2) body temperature = 38 degree C; (3) at least one respiratory symptom (cough, sore throat, rhinitis), and at least one systemic symptom (headache, muscle pain, sweating or shivering, fatigue); (4) Positive detection of influenza virus nucleic acid; (5) Aged 18 to 65 years old; (6) The patient is informed and agrees to sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Pregnant women or women in puerperium; (2) Psychiatric patients, or others who cannot cooperate or are unwilling to cooperate; (3) Receive flu vaccination within 12 months; (4) Those who participated in other trials in the past 3 months; (5) Receiving systemic steroids or other immunosuppressive agents; (6) There are significant chronic diseases or human immunodeficiency virus diseases; (7) There was a history of alcohol or drug abuse; (8) Those who have taken antiviral drugs to treat influenza.

Design outcomes

Primary

MeasureTime frame
Median symptom relief time;

Secondary

MeasureTime frame
Median fever relief time;Median cough relief time;flu symptom score;Ibuprofen use total dose;Median time of pathogen nucleic acid detection and viral load detection results turned negative;

Countries

China

Contacts

Public ContactSu Rui

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

surui114@126.com+86 13260397833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026